Colesevelam hydrochloride

This classification denotes an anti-lipidemic agent with the molecular formula (C13H27N)n.(C12H27ClN2)n.(C9H18N2O)n.(C3H7N)n.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P4SG24WI5Q, chemically known as 1-hexaminium, n,n,n-trimethyl-6-(2-propenylamino)-, chloride, polymer with (chloromethyl)oxirane, 2-propen-4-amine and n-2-propenyl-1-decanamine, hydrochloride but more generally known as colesevelam hydrochloride, which bears US NIH Compound Identifier 160051. European Medicines Agency schedules Colesevelam hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01424MIG. Most nations, for tariff and trade purposes, schedule colesevelam hydrochloride under HS 39119099 and SITC 57596. Colesevelam hydrochloride bears US NLM identifiers UMLS ID C0541154 and NCI Concept Code C28937. SMILES: As of Q4 2014, COLESEVELAM HYDROCHLORIDE remains US FDA's Preferred Term for this commodity.